Victor Hugo Figueroa Arenas, MD, MHPE Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 420 Delaware St Se, Minneapolis, MN 55455 Phone: 612-626-0697 |
Anup P. Ramani, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 516 Delaware Street Se, Clinic 1e, First Floor Pwb, Minneapolis, MN 55455 Phone: 612-636-6666 |
Paul Richard Bowlin, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2530 Chicago Ave Ste 550, Minneapolis, MN 55404 Phone: 612-813-8006 |
James Kyle Anderson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 |
Dr. Ian Schwartz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-810-0478 |
Hossein A Aliabadi, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2545 Chicago Ave, Suite 211, Minneapolis, MN 55404 Phone: 612-813-7900 |
David R Vandersteen, MD Urology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave, #550, Minneapolis, MN 55404 Phone: 612-813-8000 Fax: 612-813-8005 |
Joel W Slaton, MD Urology Medicare: Not Enrolled in Medicare Practice Location: Center For Minimally Invasive Surgery, 500 Harvard Street Se, Minneapolis, MN 55455 Phone: 612-626-8430 |
Dr. Stanley J Kogan, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |
Philip M Sweetser, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, O9, Minneapolis, MN 55415 Phone: 612-873-2811 |
Dr. John Leo Schomburg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 715 S 8th St, Minneapolis, MN 55404 Phone: 612-873-6963 |
Dr. Kendall James Feia, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 825 S 8th St, Parkside Urology Clinic, Minneapolis, MN 55404 Phone: 612-873-5252 Fax: 612-873-1600 |
Khushabu Kasabwala, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St. S. E., Mmc 394, Minneapolis, MN 55455 Phone: 612-625-8364 |
Kenneth S Koeneman, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 516 Delaware St Se, Pwb First Floor, Clinic 1e, Minneapolis, MN 55455 Phone: 612-626-6666 |
Dr. Joseph J Pariser, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 |
Martin A. Koyle, MD Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |
Bryan D Hinck, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 Fax: 612-676-8992 |
Dr. Jane Marie Lewis, MD Urology - Pediatric Urology Medicare: Not Enrolled in Medicare Practice Location: 516 Delaware St Se, 1e Pwb, Minneapolis, MN 55455 Phone: 612-624-9422 |
Joel C Hutcheson, MD Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave, #550, Minneapolis, MN 55404 Phone: 612-813-8000 Fax: 612-813-8005 |
Branden Duffey, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, Mmc 394, Minneapolis, MN 55455 Phone: 612-625-8364 |
News Archive
Costs for spinal fusion vary substantially by region, with costs being lowest in the Midwest and highest in the Northeast, according to the new research by Dr. W. Ryan Spiker and colleagues of University of Utah, Salt Lake City.
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
ASIT biotech (ASIT - BE0974289218), a Belgian clinical-stage biopharmaceutical company specialized in immunotherapy products for the treatment of allergies, is publishing a new article in the prestigious science journal ALLERGY.
Westone, the leader in high performance audio and in-ear monitoring technology, will launch their TRU™ Custom and Universal hearing protection earpieces at the 2014 NAMM Show.
Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.
› Verified 9 days ago